Device-based therapies as a boost of conventional treatment in dry eye disease

References

• Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438–510.
   Web of Science ®Google Scholar
• Tsubota K, Pflugfelder SC, Liu Z, et al. Defining dry eye from a clinical perspective. Int J Mol Sci. 2020;21:9271.
   PubMed Web of Science ®Google Scholar
• Farrand KF, Fridman M, Stillman IÖ, et al. Prevalence of diagnosed dry eye disease in the united states among adults aged 18 years and older. Am J Ophthalmol. 2017;182:90–98.
   Web of Science ®Google Scholar
• Foulks G, Lemp M, Jester J, et al. Report of the international dry eye workShop. Ocul Surf. 2007;5:1–142.
   Web of Science ®Google Scholar
• Baiula M, Spampinato S. Experimental pharmacotherapy for dry eye disease: a review. J Exp Pharmacol. 2021;13:345–358.
   PubMedGoogle Scholar
• Aragona P, Giannaccare G, Mencucci R, et al. Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review. Br J Ophthalmol. 2021;105:446–453.
   PubMed Web of Science ®Google Scholar
• Uchino M, Yokoi N, Shimazaki J, et al. Adherence to eye drops usage in dry eye patients and reasons for non-compliance: a web-based survey. J Clin Med. 2022;11(2):367.
   Web of Science ®Google Scholar
• Mohamed HB, Abd El-Hamid BN, Fathalla D, et al. Current trends in pharmaceutical treatment of dry eye disease: a review. Eur J Pharm Sci. Elsevier B.V. 2022;175:106206.
   PubMed Web of Science ®Google Scholar
• Giannaccare G, Versura P, Buzzi M, et al. Blood derived eye drops for the treatment of cornea and ocular surface diseases. Transfus Apheresis Sci. 2017;56:595–604.
   PubMed Web of Science ®Google Scholar
• Downie LE, Ng SM, Lindsley KB, et al. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease. Cochrane Database Syst Rev. 2019. DOI:10.1002/14651858.CD011016.pub2.
   PubMed Web of Science ®Google Scholar
• Giannaccare G, Pellegrini M, Sebastiani S, et al. Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease: a meta-analysis of randomized clinical trials. Cornea. 2019;38:565–573.
   PubMed Web of Science ®Google Scholar
• O’Neil EC, Henderson M, Massaro-Giordano M, et al. Advances in dry eye disease treatment. Curr Opin Ophthalmol. 2019;30:166–178.
   PubMed Web of Science ®Google Scholar
• Valencia-Nieto L, Novo-Diez A, Blanco-Vázquez M, et al. Therapeutic instruments targeting meibomian gland dysfunction. Ophthalmol Ther. 2020;9:797–807.
   PubMed Web of Science ®Google Scholar
• Chester T. A single-center retrospective trial of a blink-assisted eyelid device in treating the signs and symptoms of dry eye. Optometry Vis Sci. 2021;98(6):605–612.
   Web of Science ®Google Scholar
• Gupta PK, Holland EJ, Hovanesian J, et al. TearCare for the treatment of meibomian gland dysfunction in adult patients with dry eye disease: a masked randomized controlled trial. Cornea. 2022;41:417–426.
   PubMed Web of Science ®Google Scholar
• MiBoThermoflo - MiBo Medical Group [Internet]. cited 2022 Aug 29]. Available from 2022 Aug 29: https://mibomedicalgroup.com/mibothermoflo/.
   Google Scholar
• Xpress Eye Hydration System|Beye. cited 2022 Aug 29]; Available from 2022 Aug 29: https://www.beye.com/r/p/102.
   Google Scholar
• Lane SS, Dubiner HB, Epstein RJ, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea. 2012;31:396–404.
   PubMed Web of Science ®Google Scholar
• Blackie CA, Coleman CA, Holland EJ. The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye. Clin Ophthalmol. 2016;10:1385–1396.
   PubMed Web of Science ®Google Scholar
• Beining MW, Magnø MS, Moschowits E, et al. In-office thermal systems for the treatment of dry eye disease. Surv Ophthalmol. 2022;67:1405–1418.
   PubMed Web of Science ®Google Scholar
• Greiner JV. Long-term (3 Year) effects of a single thermal pulsation system treatment on meibomian gland function and dry eye symptoms. Eye Contact Lens. 2016;42(2):99–107.
   Web of Science ®Google Scholar
• Vigo L, Pellegrini M, Carones F, et al. Short-term effects of a novel eye mask producing heat and vibration for the treatment of meibomian gland dysfunction: a pilot study. J Ophthalmol. 2021;2021:1–5.
   Web of Science ®Google Scholar
• Vigo L, Pellegrini M, Carones F, et al. Outcomes of serial sessions of activa mask combined with intense pulsed light therapy in patients with meibomian gland dysfunction. BMC Ophthalmol. 2022;22:313.
   PubMed Web of Science ®Google Scholar
• Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med. 2003;32:78–87.
   PubMed Web of Science ®Google Scholar
• Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52:2006–2049.
   PubMed Web of Science ®Google Scholar
• Geerling G, Baudouin C, Aragona P, et al. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: proceedings of the OCEAN group meeting. Ocul Surf. 2017;15:179–192.
   PubMed Web of Science ®Google Scholar
• Jiang X, Lv H, Song H, et al. Evaluation of the safety and effectiveness of intense pulsed light in the treatment of meibomian gland dysfunction. J Ophthalmol. 2016;2016. DOI:10.1155/2016/1910694.
   Web of Science ®Google Scholar
• Dell SJ. Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol. 2017;11:1167–1173.
   PubMed Web of Science ®Google Scholar
• Prieto VG, Sadick NS, Lloreta J, et al. Effects of intense pulsed light on sun-damaged human skin, routine, and ultrastructural analysis*. Lasers Surg Med. 2002;30:82–85.
   PubMed Web of Science ®Google Scholar
• Kirn T. Intense pulsed light eradicates demodex mites. Skin Allergy News. 2002;33:37.
   Google Scholar
• Barolet D, Roberge CJ, Auger FA, et al. Regulation of Skin Collagen Metabolism In Vitro Using a Pulsed 660nm LED Light Source: clinical Correlation with a Single-Blinded Study. J Invest Dermatol. 2009;129:2751–2759.
   PubMed Web of Science ®Google Scholar
• Liu R, Rong B, Tu P, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81–90.
   PubMed Web of Science ®Google Scholar
• Huang YY, Chen ACH, Carroll JD, et al. Biphasic dose response in low level lightherapy. Dose-Response. 2009;7:358–383.
   PubMed Web of Science ®Google Scholar
• Craig JP, Chen YH, Turnbull PRK. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015;56:1965–1970.
   PubMed Web of Science ®Google Scholar
• Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf. 2019;17(1):104–110.
   Web of Science ®Google Scholar
• Xue AL, Wang MTM, Ormonde SE, et al. Randomised double-masked placebo-controlled trial of the cumulative treatment efficacy profile of intense pulsed light therapy for meibomian gland dysfunction. Ocul Surf. 2020;18:286–297.
   PubMed Web of Science ®Google Scholar
• Yan X, Hong J, Jin X, et al. The efficacy of intense pulsed light combined with meibomian gland expression for the treatment of dry eye disease due to meibomian gland dysfunction: a multicenter, randomized controlled trial. Eye Contact Lens. 2021;47:45–53.
   PubMed Web of Science ®Google Scholar
• Giannaccare G, Taroni L, Senni C, et al. Intense pulsed light therapy in the treatment of meibomian gland dysfunction: current perspectives. Clin Optom (Auckl). 2019;11:113–126.
   PubMed Web of Science ®Google Scholar
• Vigo L, Giannaccare G, Sebastiani S, et al. Intense pulsed light for the treatment of dry eye owing to meibomian gland dysfunction. J Vis Exp. 2019. DOI:10.3791/57811.
   PubMed Web of Science ®Google Scholar
• Kim WS, Glen Calderhead R. Is light-emitting diode phototherapy (Led-Lllt) really effective? Laser Ther. 2011;20:205–215.
   PubMedGoogle Scholar
• Gao X, Xing D. Molecular mechanisms of cell proliferation induced by low power laser irradiation. J Biomed Sci. 2009;16:1–16.
   Web of Science ®Google Scholar
• D’Souza S, Padmanabhan Nair A, Iyappan G, et al. Clinical and molecular outcomes after combined intense pulsed light therapy with low-level light therapy in recalcitrant evaporative dry eye disease with meibomian gland dysfunction. Cornea. 2022;41(9):1080–1087.
   Web of Science ®Google Scholar
• Stonecipher K, Abell TG, Chotiner B, et al. Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction. Clin Ophthalmol. 2019;13:993–999.
   PubMed Web of Science ®Google Scholar
• Giannaccare G, Pellegrini M, Scalzo GC, et al. Low-level light therapy versus intense pulsed light for the treatment of meibomian gland dysfunction: preliminary results from a prospective randomized comparative study. Cornea. 2022. DOI:10.1097/ICO.0000000000002997.
   PubMedGoogle Scholar
• Schanzlin D, Owen JP, Klein S, et al. Efficacy of the systane iLux thermal pulsation system for the treatment of meibomian gland dysfunction after 1 week and 1 month: a prospective study. Eye Contact Lens. 2022;48:155–161.
   PubMed Web of Science ®Google Scholar
• Tauber J, Owen J, Bloomenstein M, et al. Comparison of the iLUX and the lipiflow for the treatment of meibomian gland dysfunction and symptoms: a randomized clinical trial. Clin Ophthalmol. 2020;14:405–418.
   PubMed Web of Science ®Google Scholar
• Wesley G, Bickle K, Downing J, et al. Comparison of two thermal pulsation systems in the treatment of meibomian gland dysfunction: a randomized, multicenter study. Optometry Vision Sci. 2022;99:323–332.
   PubMed Web of Science ®Google Scholar
• Fraccalvieri M, Salomone M, Di Santo C, et al. Quantum molecular resonance technology in hard-to-heal extremity wounds: histological and clinical results. Int Wound J. 2017;14:1313–1322.
   PubMed Web of Science ®Google Scholar
• Sella S, Adami V, Amati E, et al. In-vitro analysis of quantum molecular resonance effects on human mesenchymal stromal cells. PLoS One. 2018;13:e0190082.
   PubMed Web of Science ®Google Scholar
• Pedrotti E, Bosello F, Fasolo A, et al. Transcutaneous periorbital electrical stimulation in the treatment of dry eye. Br J Ophthalmol. 2017;101:814–819.
   PubMed Web of Science ®Google Scholar
• Ferrari G, Colucci A, Barbariga M, et al. High frequency electrotherapy for the treatment of meibomian gland dysfunction. Cornea. 2019;38:1424–1429.
   PubMed Web of Science ®Google Scholar
• Dry Eye & Blepharitis Device | Eyelid Cleaning Brush | NuLids [Internet]. cited 2022 Aug 29]. Available from 2022 Aug 29: https://nulids.com/.
   Google Scholar
• Mohammad-Rabei H, Arabi A, Shahraki T, et al. Role of blepharoexfoliation in demodex blepharitis: a randomized comparative study. Cornea. 2022 Apr 14; 9900. DOI:10.1097/ICO.0000000000003046.
   Google Scholar
• Zhu D, Gupta RR, Stein RL, et al. Randomized prospective evaluation of microblepharoexfoliation blephEx as adjunctive therapy in the treatment of Chalazia. Cornea. 2022;Publish Ahead of Print. DOI:10.1097/ICO.0000000000003090.
   Google Scholar
• Pattar GR, Jerkins G, Evans DG, et al. Symptom improvement in dry eye subjects following intranasal tear neurostimulation: results of two studies utilizing a controlled adverse environment. Ocul Surf. 2020;18:249–257.
   PubMed Web of Science ®Google Scholar
• Sheppard JD, Torkildsen GL, Geffin JA, et al. Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: results from two pivotal clinical trials. Ocul Surf. 2019;17:142–150.
   PubMed Web of Science ®Google Scholar
• Lilley J, O’neil EC, Bunya VY, et al. Efficacy of an intranasal tear neurostimulator in Sjögren syndrome patients. Clin Ophthalmol. 2021;15:4291.
   PubMed Web of Science ®Google Scholar
• O’Neil EC, Henderson M, Massaro-Giordano M, et al. Advances in dry eye disease treatment. Curr Opin Ophthalmol. 2019;30:166–178.
   PubMed Web of Science ®Google Scholar
• Yang L, Pazo EE, Zhang Q, et al. Treatment of contact lens related dry eye with intense pulsed light. Contact Lens Anterior Eye. 2022;45:101449.
   PubMed Web of Science ®Google Scholar
• Blackie CA, Coleman CA, Nichols KK, et al. A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day. Clin Ophthalmol. 2018;12:169–183.
   PubMed Web of Science ®Google Scholar